Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial
Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1 GBS is a “polio-like” inflammatory autoimmune […]
Vaccination Exemption Rates Increased Among U.S. Kindergarteners in 40 States
A new report published in the U.S. Centers for Disease Control and Prevention’s (CDC) Morbidity and Mortality Weekly Report (MMWR) states that during the 2022–2023 school year, vaccination coverage remained at 93 percent for all reported vaccines. However, the vaccine exemption rate increased 0.4 percentage points to three percent. Exemptions increased in 41 states, and […]
15-Month-Old Girl Dies Two Days After ‘Well-Baby Visit’ Vaccinations
A 15-month-old girl died in Warwick, New York on Oct. 19, 2023, two days after receiving three shots of five vaccines during a routine well-baby visit with a pediatrician at the Herbert Kania Pediatric Group. Melody Rain Palombi-Malmgren was a “perfectly healthy child,” according to her mother, Katherine Palombi. She was administered the varicella (chickenpox), […]
Study Shows Declining Childhood Vaccination Rates in U.S.
A study published recently in the journal Pediatrics showed that in 2019 more than one in six children in the United States aged 19 to 35 months old did not receive all of the doses of vaccines recommended by the U.S. Centers for Disease Control and Prevention (CDC).1 The study examined the vaccination uptake rates […]
Childhood Vaccination Programs Face Major Cuts in Federal Funding
State vaccination programs for children will face a reduction in funding from U.S. Centers for Disease Control and Prevention (CDC) grants. The federal immunization grant program, which funds the Vaccines for Children (VFC) program, totaled approximately $680 million last year.1 The reduction in funding is alleged to be due to the debt ceiling deal reached […]
Twelve Infants Die During Clinical Trials for FDA-Endorsed RSV Drug
On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to provide protection for infants from respiratory syncytial virus (RSV) disease and other lower respiratory tract infections during their first year of life.1 […]
